These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 3491953)
1. Stimulation of cytotoxic T-lymphocyte responses by rabies virus glycoprotein and identification of an immunodominant domain. Macfarlan RI; Dietzschold B; Koprowski H Mol Immunol; 1986 Jul; 23(7):733-41. PubMed ID: 3491953 [TBL] [Abstract][Full Text] [Related]
2. Antigenic structure of rabies virus glycoprotein: ordering and immunological characterization of the large CNBr cleavage fragments. Dietzschold B; Wiktor TJ; Macfarlan R; Varrichio A J Virol; 1982 Nov; 44(2):595-602. PubMed ID: 6183450 [TBL] [Abstract][Full Text] [Related]
3. Protection against rabies in mice by a cytotoxic T cell clone recognizing the glycoprotein of rabies virus. Kawano H; Mifune K; Ohuchi M; Mannen K; Cho S; Hiramatsu K; Shichijo A J Gen Virol; 1990 Feb; 71 ( Pt 2)():281-7. PubMed ID: 2307962 [TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of a CNBr cleavage peptide of influenza viral hemagglutinin stimulatory for mouse cytolytic T lymphocytes. Wabuke-Bunoti MA; Fan DP J Immunol; 1983 May; 130(5):2386-91. PubMed ID: 6601150 [TBL] [Abstract][Full Text] [Related]
5. Rabies virus-specific T cell hybridomas: identification of class II MHC-restricted T-cell epitopes using synthetic peptides. Celis E; Ou D; Dietzschold B; Otvos L; Koprowski H Hybridoma; 1989 Jun; 8(3):263-75. PubMed ID: 2787273 [TBL] [Abstract][Full Text] [Related]
6. Target cells of cytotoxic T lymphocytes directed to the individual structural proteins of rabies virus. Fujii H; Mannen K; Takita-Sonoda Y; Hirai K; Cruz-Abrenica MS; Kawano Y; Nishizono A; Mifune K Microbiol Immunol; 1994; 38(9):721-6. PubMed ID: 7854213 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the induction of specific cytotoxic T lymphocytes following immunization of F1 hybrid mice with rabies antigens. Morgeaux S; Joffret ML; Leclerc C; Sureau P; Perrin P Res Virol; 1989; 140(3):193-206. PubMed ID: 2547236 [TBL] [Abstract][Full Text] [Related]
8. T cell responses to cleaved rabies virus glycoprotein and to synthetic peptides. Macfarlan RI; Dietzschold B; Wiktor TJ; Kiel M; Houghten R; Lerner RA; Sutcliffe JG; Koprowski H J Immunol; 1984 Nov; 133(5):2748-52. PubMed ID: 6332859 [TBL] [Abstract][Full Text] [Related]
9. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response. Nahill SR; Welsh RM J Exp Med; 1993 Feb; 177(2):317-27. PubMed ID: 8093891 [TBL] [Abstract][Full Text] [Related]
10. Murine T cell clones directed to rabies virus: isolation and some of their properties. Cho S; Narahara H; Mifune K; Kawai A J Gen Virol; 1987 Apr; 68 ( Pt 4)():1115-23. PubMed ID: 3106564 [TBL] [Abstract][Full Text] [Related]
11. Detection of anti-rabies virus cytotoxic T lymphocytes in mice of four distinct H-2 haplotypes using target cells persistently infected with ERA rabies virus. Sugamata M; Ewalt LC; Perry LL; Lodmell DL J Virol Methods; 1990 Jul; 29(1):1-11. PubMed ID: 1698803 [TBL] [Abstract][Full Text] [Related]
12. Immunity against the European bat rabies (Duvenhage) virus induced by rabies vaccines: an experimental study in mice. Lafon M; Bourhy H; Sureau P Vaccine; 1988 Aug; 6(4):362-8. PubMed ID: 2461007 [TBL] [Abstract][Full Text] [Related]
13. Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptides. Carbone FR; Moore MW; Sheil JM; Bevan MJ J Exp Med; 1988 Jun; 167(6):1767-79. PubMed ID: 2455012 [TBL] [Abstract][Full Text] [Related]
14. Amplification of rabies virus-induced stimulation of human T-cell lines and clones by antigen-specific antibodies. Celis E; Wiktor TJ; Dietzschold B; Koprowski H J Virol; 1985 Nov; 56(2):426-33. PubMed ID: 3877176 [TBL] [Abstract][Full Text] [Related]
15. Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene. Wiktor TJ; Macfarlan RI; Reagan KJ; Dietzschold B; Curtis PJ; Wunner WH; Kieny MP; Lathe R; Lecocq JP; Mackett M Proc Natl Acad Sci U S A; 1984 Nov; 81(22):7194-8. PubMed ID: 6095272 [TBL] [Abstract][Full Text] [Related]
16. In vivo CTL immunity can be elicited by in vitro reconstituted MHC/peptide complex. Sakita I; Hörig H; Sun R; Wang F; Nathenson SG J Immunol Methods; 1996 Jun; 192(1-2):105-15. PubMed ID: 8699005 [TBL] [Abstract][Full Text] [Related]
17. Predominance of MHC class II-restricted CD4+ cytotoxic T cells against mouse hepatitis virus A59. Heemskerk MH; Schoemaker HM; Spaan WJ; Boog CJ Immunology; 1995 Apr; 84(4):521-7. PubMed ID: 7790024 [TBL] [Abstract][Full Text] [Related]
18. Failure or success in the restoration of virus-specific cytotoxic T lymphocyte response defects by dendritic cells. Kast WM; Boog CJ; Roep BO; Voordouw AC; Melief CJ J Immunol; 1988 May; 140(9):3186-93. PubMed ID: 2834454 [TBL] [Abstract][Full Text] [Related]
19. The association of the rabies glycoprotein with liposome (immunosome) induces an in vitro specific release of interleukin 2. Oth D; Mercier G; Perrin P; Joffret ML; Sureau P; Thibodeau L Cell Immunol; 1987 Aug; 108(1):220-6. PubMed ID: 3496973 [TBL] [Abstract][Full Text] [Related]
20. Generation and characterization of peptide-specific, MHC-restricted cytotoxic T lymphocyte (CTL) and helper T cell lines from unprimed T cells under microculture conditions. Sambhara SR; Upadhya AG; Miller RG J Immunol Methods; 1990 Jun; 130(1):101-9. PubMed ID: 2141621 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]